Voxel S.A. (VOX) - Total Assets
Based on the latest financial reports, Voxel S.A. (VOX) holds total assets worth zł706.69 Million PLN (≈ $194.49 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See VOX total equity for net asset value and shareholders' equity analysis.
Voxel S.A. - Total Assets Trend (2010–2025)
This chart illustrates how Voxel S.A.'s total assets have evolved over time, based on quarterly financial data.
Voxel S.A. - Asset Composition Analysis
Current Asset Composition (December 2025)
Voxel S.A.'s total assets of zł706.69 Million consist of 28.6% current assets and 71.4% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 1.8% |
| Accounts Receivable | zł125.61 Million | 17.8% |
| Inventory | zł23.16 Million | 3.3% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł36.51 Million | 5.2% |
| Goodwill | zł94.65 Million | 13.4% |
Asset Composition Trend (2010–2025)
This chart illustrates how Voxel S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Voxel S.A. worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Voxel S.A.'s current assets represent 28.6% of total assets in 2025, an increase from 20.2% in 2010.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2025, down from 5.3% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 12.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 17.8% of total assets.
Voxel S.A. Competitors by Total Assets
Key competitors of Voxel S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
|
India | Rs31.46 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Check-Cap Ltd.
NASDAQ:MBAI
|
USA | $7.49 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Voxel S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.40 | 1.21 | 0.91 |
| Quick Ratio | 1.24 | 1.04 | 0.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł57.31 Million | zł36.86 Million | zł-12.07 Million |
Voxel S.A. - Advanced Valuation Insights
This section examines the relationship between Voxel S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.59 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | 10.5% |
| Total Assets | zł706.69 Million |
| Market Capitalization | $280.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Voxel S.A.'s assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Voxel S.A.'s assets grew by 10.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Voxel S.A. (2010–2025)
The table below shows the annual total assets of Voxel S.A. from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | zł706.69 Million ≈ $194.49 Million |
+10.52% |
| 2024-12-31 | zł639.44 Million ≈ $175.98 Million |
+20.87% |
| 2023-12-31 | zł529.03 Million ≈ $145.60 Million |
+13.20% |
| 2022-12-31 | zł467.35 Million ≈ $128.62 Million |
-5.59% |
| 2021-12-31 | zł495.05 Million ≈ $136.24 Million |
+12.97% |
| 2020-12-31 | zł438.23 Million ≈ $120.61 Million |
+29.69% |
| 2019-12-31 | zł337.91 Million ≈ $93.00 Million |
+19.69% |
| 2018-12-31 | zł282.33 Million ≈ $77.70 Million |
+18.10% |
| 2017-12-31 | zł239.05 Million ≈ $65.79 Million |
+7.14% |
| 2016-12-31 | zł223.12 Million ≈ $61.40 Million |
+5.17% |
| 2015-12-31 | zł212.15 Million ≈ $58.39 Million |
-1.30% |
| 2014-12-31 | zł214.95 Million ≈ $59.16 Million |
-0.21% |
| 2013-12-31 | zł215.40 Million ≈ $59.28 Million |
+28.66% |
| 2012-12-31 | zł167.43 Million ≈ $46.08 Million |
-17.64% |
| 2011-12-31 | zł203.30 Million ≈ $55.95 Million |
+18.03% |
| 2010-12-31 | zł172.25 Million ≈ $47.41 Million |
-- |
About Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.